{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:10:52Z","timestamp":1790683852878,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,17]]},"DOI":"10.7759\/cureus.75906","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T05:18:58Z","timestamp":1734499138000},"source":"Crossref","is-referenced-by-count":3,"title":["Green Nail in a Patient With Psoriasis Receiving Deucravacitinib"],"prefix":"10.7759","author":[{"given":"Yoshihito","family":"Mima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Norimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Greenish pigmentation of the nail plates from bacillus pyocyaneus infection","volume":"68","author":"Goldman L","year":"1944","unstructured":"Goldman L, Fox HH. Greenish pigmentation of the nail plates from bacillus pyocyaneus infection. AMA Arch Dermatol Syphilol. 1944, 68:136-7.","journal-title":"AMA Arch Dermatol Syphilol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_277_19","article-title":"Chloronychia: the Goldman-Fox syndrome - implications for patients and healthcare workers","volume":"65","author":"Schwartz RA","year":"2020","unstructured":"Schwartz RA, Reynoso-Vasquez N, Kapila R. Chloronychia: the Goldman-Fox syndrome - implications for patients and healthcare workers. Indian J Dermatol. 2020, 65:1-4. 10.4103\/ijd.IJD_277_19","journal-title":"Indian J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm0706497","article-title":"Images in clinical medicine. Green nails","volume":"360","author":"Hengge UR","year":"2009","unstructured":"Hengge UR, Bardeli V. Images in clinical medicine. Green nails. N Engl J Med. 2009, 360:1125. 10.1056\/NEJMicm0706497","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1086\/321890","article-title":"Outbreak of sternal surgical site infections due to Pseudomonas aeruginosa traced to a scrub nurse with onychomycosis","volume":"33","author":"McNeil SA","year":"2001","unstructured":"McNeil SA, Nordstrom-Lerner L, Malani PN, Zervos M, Kauffman CA. Outbreak of sternal surgical site infections due to Pseudomonas aeruginosa traced to a scrub nurse with onychomycosis. Clin Infect Dis. 2001, 33:317-23. 10.1086\/321890","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2010.01827.x","article-title":"Transmission of Pseudomonas aeruginosa from nail to wound infection","volume":"37","author":"Vergilis I","year":"2011","unstructured":"Vergilis I, Goldberg LH, Landau J, Maltz A. Transmission of Pseudomonas aeruginosa from nail to wound infection. Dermatol Surg. 2011, 37:105-6. 10.1111\/j.1524-4725.2010.01827.x","journal-title":"Dermatol Surg"},{"key":"ref6","article-title":"The role of Pseudomonas aeruginosa in nail disease","volume":"41","author":"Stone OJ","year":"1963","unstructured":"Stone OJ, Mullins JF. The role of Pseudomonas aeruginosa in nail disease. J Invest Dermatol. 1963, 41:25-6.","journal-title":"J Invest Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb JE","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, et al.. Psoriasis. Nat Rev Dis Primers. 2016, 2:16082. 10.1038\/nrdp.2016.82","journal-title":"Nat Rev Dis Primers"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi R","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013, 133:377-85. 10.1038\/jid.2012.339","journal-title":"J Invest Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong AW","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020, 323:1945-60. 10.1001\/jama.2020.4006","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita J","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017, 76:377-90. 10.1016\/j.jaad.2016.07.064","journal-title":"J Am Acad Dermatol"},{"key":"ref11","article-title":"Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine","volume":"33","author":"Alwan W","year":"2015","unstructured":"Alwan W, Nestle FO. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. Clin Exp Rheumatol. 2015, 33:2-6.","journal-title":"Clin Exp Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis","volume":"201","author":"Hawkes JE","year":"2018","unstructured":"Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J Immunol. 2018, 201:1605-13. 10.4049\/jimmunol.1800013","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15913","article-title":"Pathophysiology of psoriasis: a review","volume":"48","author":"Yamanaka K","year":"2021","unstructured":"Yamanaka K, Yamamoto O, Honda T. Pathophysiology of psoriasis: a review. J Dermatol. 2021, 48:722-31. 10.1111\/1346-8138.15913","journal-title":"J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi K","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerb\u00e4ck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021, 397:754-66. 10.1016\/S0140-6736(21)00184-7","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.07.002","article-title":"Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial","volume":"88","author":"Armstrong AW","year":"2023","unstructured":"Armstrong AW, Gooderham M, Warren RB, et al.. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial. J Am Acad Dermatol. 2023, 88:29-39. 10.1016\/j.jaad.2022.07.002","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2022.2008240","article-title":"TYK2 inhibition: changing the treatment landscape for psoriasis?","volume":"18","author":"Abduelmula A","year":"2022","unstructured":"Abduelmula A, Gooderham MJ. TYK2 inhibition: changing the treatment landscape for psoriasis?. Expert Rev Clin Immunol. 2022, 18:185-7. 10.1080\/1744666X.2022.2008240","journal-title":"Expert Rev Clin Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15832","article-title":"Clinical analysis of Pseudomonas aeruginosa-positive and -negative green nail syndrome cases: a single center retrospective analysis","volume":"48","author":"Lee H","year":"2021","unstructured":"Lee H, Mun JH, Cho S, Park H. Clinical analysis of Pseudomonas aeruginosa-positive and -negative green nail syndrome cases: a single center retrospective analysis. J Dermatol. 2021, 48:1073-6. 10.1111\/1346-8138.15832","journal-title":"J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000047528.79014.CF","article-title":"IL-10 controls Aspergillus fumigatus- and Pseudomonas aeruginosa-specific T-cell response in cystic fibrosis","volume":"53","author":"Casaulta C","year":"2003","unstructured":"Casaulta C, Sch\u00f6ni MH, Weichel M, et al.. IL-10 controls Aspergillus fumigatus- and Pseudomonas aeruginosa-specific T-cell response in cystic fibrosis. Pediatr Res. 2003, 53:313-9. 10.1203\/01.PDR.0000047528.79014.CF","journal-title":"Pediatr Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.12.7263","article-title":"Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation","volume":"176","author":"Shaw MH","year":"2006","unstructured":"Shaw MH, Freeman GJ, Scott MF, Fox BA, Bzik DJ, Belkaid Y, Yap GS. Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation. J Immunol. 2006, 176:7263-71. 10.4049\/jimmunol.176.12.7263","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14796","article-title":"Peripheral cytokine interleukin-10 alleviates perihematomal edema after intracerebral hemorrhage via interleukin-10 receptor\/JAK1\/STAT3 signaling","volume":"30","author":"Xu Y","year":"2024","unstructured":"Xu Y, Wang K, Dai Y, et al.. Peripheral cytokine interleukin-10 alleviates perihematomal edema after intracerebral hemorrhage via interleukin-10 receptor\/JAK1\/STAT3 signaling. CNS Neurosci Ther. 2024, 30:e14796. 10.1111\/cns.14796","journal-title":"CNS Neurosci Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/324526-green-nail-in-a-patient-with-psoriasis-receiving-deucravacitinib","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T05:19:00Z","timestamp":1734499140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/324526-green-nail-in-a-patient-with-psoriasis-receiving-deucravacitinib"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.75906","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}